PARP1/7 dual inhibitor (Duke Street Bio)

N/A

Report date: 2025/06/11 10:26:29
NME

Base Information

Drug NamePARP1/7 dual inhibitor (Duke Street Bio)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsAnticancer protein kinase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke Street Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDuke Street Bio Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A